Table 3.
Body weight, serum glucose level, lipid profile, liver and kidney functions in control and obese groups without ZnSO4 tretatment, low dose (15 mg) ZnSO4 treatment, and high dose (30 mg) ZnSO4 treatment in male rats.
| Studied parameters | Control group | Obese group | ||||
|---|---|---|---|---|---|---|
| Without ZnSO4 | Low dose ZnSO4 | High dose ZnSO4 | Without ZnSO4 | Low dose ZnSO4 | High dose ZnSO4 | |
| Body weight (g) | 313.4 ± 22.8bc | 300.6 ± 6.4bc | 289.4 ± 24.9c | 419.0 ± 8.2a | 324.3 ± 42.7b | 303.9 ± 20.4b |
| Glucose (mg/dl) | 92.7 ± 10.7cd | 93.7 ± 7.7bcd | 91.0 ± 6.6cd | 130.3 ± 3.5a | 94.2 ± 6.6bcd | 96.7 ± 9.8bc |
| Lipid profile | ||||||
| Lipids (mg/dl) | 347.4 ± 19.1b | 347.9 ± 21.8b | 323.5 ± 25.4bc | 406.5 ± 22.6a | 355.7 ± 14.4b | 343.3 ± 16..2bc |
| Cholesterol (mg/dl) | 97.0 ± 7.3bc | 97.7 ± 14.2bc | 99.0 ± 26.8bc | 129.0 ± 10.3a | 111.0 ± 28.0ab | 112.3 ± 13.6ab |
| Triglyceride (mg/dl) | 94.7 ± 10.4c | 90.0 ± 18.2c | 90.7 ± 15.0c | 196.3 ± 17.3a | 157.3 ± 7.4b | 153.3 ± 12.0b |
| Liver enzymes | ||||||
| GOT (U/L) | 167.3 ± 13.2bcd | 162.2 ± 13.6cde | 131.4 ± 13.0ef | 275.0 ± 57.1a | 199.2 ± 27.7b | 173.0 ± 10.7bc |
| GPT (U/L) | 63.1 ± 4.1b | 48.9 ± 7.6cd | 47.0 ± 8.9cde | 93.1 ± 5.0a | 40.9 ± 5.4ef | 41.1 ± 5.8def |
| Kidney functions | ||||||
| Urea (mg/dl) | 34.0 ± 2.0e | 37.3 ± 3.0bcde | 37.0 ± 4.3cde | 42.2 ± 2.6a | 38.3 ± 1.9abcd | 38.4 ± 2.1abc |
| Uric acid (mg/dl) | 2.6 ± 0.4e | 3.0 ± 0.4de | 3.3 ± 0.5cde | 2.6 ± 0.4e | 3.3 ± 0.6cde | 3.4 ± 0.2cd |
| Creatinine (mg/dl) | 0.6 ± 0.07ab | 0.7 ± 0.07a | 0.6 ± 0.06ab | 0.6 ± 0.05ab | 0.6 ± 0.07ab | 0.6 ± 0.08ab |
Data was expressed using mean ± SD.
Means in the same raw with small common letters are not significant (i.e. means with different letters are significant).
SD standard deviation.